Ampio Pharma Revenue, Profits - AMPE Annual Income Statement

Add to My Stocks
$0.52 $0.02 (4%) AMPE stock closing price Sep 20, 2018 (Closing)

Fundamental analysis of AMPE stock involves analyzing its financial statements, apart from checking the Ampio Pharma stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. Like any other income statement, the AMPE income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. The Ampio Pharma profit and loss statement for 2017 shows a net profit of $-51.89M. Profits for last year was $-19.16M. Apart from this an investor should also check Ampio Pharma assets and Ampio Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Ampio Pharma Revenues or Net Sales
--1.16M-------
Cost Of Goods Sold (COGS)----------
Ampio Pharma Gross Profit
----------
Research & Development Expense10.42M10.54M18.96M26.92M18.28M7.49M6.64M1.97M--
Selling General & Admin Expense5.14M6.53M15.13M12.22M5.78M4.37M4.5M4.73M--
Income Before Depreciation Depletion Amortization-15.56M-17.08M-33.3M-39.07M-24.02M-11.82M-11.13M-6.7M-0.02M-0.02M
Depreciation Depletion Amortization----------
Non Operating Income-36.32M-2.08M-0.41M--0.5M--7.13M-1.32M--
Interest Expense----------
Ampio Pharma Pretax Income
-51.89M-19.16M-33.71M-39.04M-24.52M-11.59M-18.27M-8.05M-0.02M-0.03M
Provision for Income Taxes----------
MinorityInterest---1.7M-0.92M-0.51M-----
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-51.89M-19.16M-33.71M-39.04M-24.52M-11.59M-18.35M-8.05M-0.02M-0.03M
Extraordinary Items & Discontinued Operations----------
Ampio Pharma Profit/ Loss (Net Income)
-51.89M-19.16M-32.01M-38.12M-24M-11.59M-18.35M-8.05M-0.02M-0.03M
Average Shares used to compute Diluted EPS-53.77M51.99M50.23M38.29M33.98M26.01M---
Average Shares used to compute Basic EPS-53.77M51.99M50.23M38.29M33.98M26.01M---
Income Before Nonrecurring Items--17.06M-32.01M-38.13M-24.01M-11.59M-18.36M---
Income from Nonrecurring Items--2.11M--------
Ampio Pharma Earnings Per Share Basic Net
-0.75-0.36-0.62-0.76-0.63-0.34-0.71---
Ampio Pharma Earnings Per Share Diluted Net
--0.36-0.62-0.76-0.63-0.34-0.71---
EPS Diluted Before Nonrecurring Items--0.32-0.62-0.76-0.63-0.34-0.71---
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.700.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Horizon Pharma financial analysis

The key things to look for in an income statement while doing Ampio Pharma stock analysis are:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AMPE stock has a topline or revenue of $- for 2017 as per this Ampio Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AMPE stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The AMPE financials along with Ampio Pharma historical stock prices provide a lot of details about the firm.

Ampio Pharma Income Statement - Key Financial Ratios

Operating Margin
0
Net Profit Margin
0